Perrigo Net Income 2010-2025 | PRGO

Perrigo net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Perrigo Annual Net Income
(Millions of US $)
2024 $-172
2023 $-13
2022 $-141
2021 $-69
2020 $-163
2019 $146
2018 $131
2017 $120
2016 $-4,013
2015 $43
2015 $136
2014 $233
2013 $442
2012 $402
2011 $339
2010 $224
2009 $146
Perrigo Quarterly Net Income
(Millions of US $)
2025-03-31 $-6
2024-12-31 $-44
2024-09-30 $-21
2024-06-30 $-108
2024-03-31 $2
2023-12-31 $-32
2023-09-30 $14
2023-06-30 $8
2023-03-31 $-3
2022-12-31 $-24
2022-09-30 $-49
2022-06-30 $-65
2022-03-31 $-2
2021-12-31 $10
2021-09-30 $-59
2021-06-30 $-58
2021-03-31 $38
2020-12-31 $-175
2020-09-30 $-155
2020-06-30 $61
2020-03-31 $106
2019-12-31 $-19
2019-09-30 $92
2019-06-30 $9
2019-03-31 $64
2018-12-31 $82
2018-09-30 $-68
2018-06-30 $36
2018-03-31 $81
2017-12-31 $73
2017-09-30 $45
2017-06-30 $-70
2017-03-31 $72
2016-12-31 $-1,359
2016-09-30 $-1,590
2016-06-30 $-534
2016-03-31 $-529
2015-12-31 $-174
2015-09-30 $261
2015-06-30 $-22
2015-03-31 $-22
2014-12-31 $70
2014-09-30 $96
2014-06-30
2014-03-31 $48
2013-12-31 $-86
2013-09-30 $111
2013-06-30
2013-03-31 $112
2012-12-31 $106
2012-09-30 $106
2012-06-30
2012-03-31 $116
2011-12-31 $100
2011-09-30 $70
2011-06-30
2011-03-31 $89
2010-12-31 $90
2010-09-30 $74
2010-06-30
2010-03-31 $62
2009-12-31 $61
2009-09-30 $52
2009-06-30
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.651B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.440B 27.47
Boston Scientific (BSX) United States $154.602B 38.70
Stryker (SYK) United States $143.752B 30.06
EssilorLuxottica (ESLOY) France $130.179B 0.00
Medtronic (MDT) Ireland $103.476B 14.67
Haleon (HLN) United Kingdom $50.205B 28.56
Lonza Group Ag (LZAGY) Switzerland $49.251B 0.00
ResMed (RMD) United States $35.607B 26.74
GE HealthCare Technologies (GEHC) United States $31.667B 15.03
Agilent Technologies (A) United States $30.942B 20.44
Terumo (TRUMY) Japan $27.686B 35.96
Insulet (PODD) United States $22.616B 88.77
Koninklijke Philips (PHG) Netherlands $21.196B 15.24
Zimmer Biomet Holdings (ZBH) United States $18.329B 11.77
Baxter (BAX) United States $15.457B 11.54
Smith & Nephew SNATS (SNN) United Kingdom $12.539B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.090B 21.19
Lantheus Holdings (LNTH) United States $5.110B 12.89
Prestige Consumer Healthcare (PBH) United States $4.237B 18.93
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.175B 23.41
Haemonetics (HAE) United States $3.173B 14.46
Envista Holdings (NVST) United States $2.834B 23.55
GN Store Nord (GNNDY) Denmark $2.054B 17.01
QuidelOrtho (QDEL) United States $2.011B 13.83
LeMaitre Vascular (LMAT) United States $1.839B 41.11
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.315B 16.83
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.185B 12.03
Green Thumb Industries (GTBIF) United States $1.145B 25.76
Kestra Medical Technologies (KMTS) United States $1.139B 0.00
BioLife Solutions (BLFS) United States $1.035B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.04
InMode (INMD) Israel $0.899B 9.06
Evolus (EOLS) United States $0.624B 0.00
CeriBell (CBLL) United States $0.599B 0.00
Curaleaf Holdings (CURLF) Canada $0.569B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Valneva SE (VALN) France $0.517B 0.00
Owens & Minor (OMI) United States $0.498B 4.13
Capricor Therapeutics (CAPR) United States $0.468B 0.00
Tilray Brands (TLRY) Canada $0.445B 0.00
Surmodics (SRDX) United States $0.410B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Canopy Growth (CGC) Canada $0.336B 0.00
Cresco Labs (CRLBF) United States $0.326B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Aurora Cannabis (ACB) Canada $0.309B 55.00
Sanara MedTech (SMTI) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.254B 21.40
Verano Holdings (VRNOF) United States $0.248B 0.00
Sanuwave Health (SNWV) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.231B 10.48
Brainsway (BWAY) Israel $0.203B 53.65
Biote (BTMD) United States $0.201B 5.66
OraSure Technologies (OSUR) United States $0.189B 0.00
Quanterix (QTRX) United States $0.188B 0.00
Omeros (OMER) United States $0.185B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.183B 0.00
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Utah Medical Products (UTMD) United States $0.175B 14.22
Exagen (XGN) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.137B 16.86
Jin Medical (ZJYL) China $0.123B 0.00
TerrAscend (TSNDF) Canada $0.119B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Fonar (FONR) United States $0.088B 11.30
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Veru (VERU) United States $0.073B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Jushi Holdings (JUSHF) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.058B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.037B 12.92
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.71
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00